Replimune (REPL) Other Non Operating Income (2017 - 2025)
Replimune's (REPL) quarterly Other Non Operating Income came in at -$580000.0 in Q4 2025, up 82.32% year-on-year from -$318117.7 in Q4 2024, and up 33.79% quarter-over-quarter from -$876000.0 in Q3 2025.
Replimune (REPL) Other Non Operating Income (2017 - 2025) Analysis & Trends
Replimune has disclosed Other Non Operating Income across 9 years of filings, most recently posting -$580000.0 for Q4 2025.
- Other Non Operating Income for Q4 2025 came in at -$580000.0, up 82.32% year-over-year; the trailing twelve-month figure through Dec 2025 was -$217000.0 (up 84.31% YoY), and the FY2025 annual result was -$202000.0, down 126.2% from the prior year.
- Other Non Operating Income came in at -$580000.0 for Q4 2025 at Replimune, up from -$876000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $2.0 million in Q3 2024 to a low of -$3.3 million in Q4 2024.
- The 5-year median for Other Non Operating Income is -$246500.0 (2021), against an average of -$347000.0.
- Across the five-year window, Other Non Operating Income tumbled 800.0% in 2021 and surged 814.29% in 2023, its largest moves.
- Replimune's Other Non Operating Income stood at -$241000.0 in 2021, then surged by 161.0% to $147000.0 in 2022, then soared by 814.29% to $1.3 million in 2023, then sank by 344.12% to -$3.3 million in 2024, then soared by 82.32% to -$580000.0 in 2025.
- The last three Other Non Operating Income figures came in at -$580000.0 (Q4 2025), -$876000.0 (Q3 2025), and $591000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Replimune | 780.01 Mn | 510.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -580,000.00 |
| Sep 30, 2025 | -876,000.00 |
| Jun 30, 2025 | 591,000.00 |
| Mar 31, 2025 | 648,000.00 |
| Dec 31, 2024 | -3.28 Mn |
| Sep 30, 2024 | 2.03 Mn |
| Jun 30, 2024 | 406,000.00 |
| Mar 31, 2024 | -536,000.00 |
| Dec 31, 2023 | 1.34 Mn |
| Sep 30, 2023 | -1.41 Mn |
| Jun 30, 2023 | 1.37 Mn |
| Mar 31, 2023 | -1.15 Mn |
| Dec 31, 2022 | 147,000.00 |
| Sep 30, 2022 | -2.66 Mn |
| Jun 30, 2022 | -2.02 Mn |
| Mar 31, 2022 | -210,000.00 |
| Dec 31, 2021 | -241,000.00 |
| Sep 30, 2021 | -356,000.00 |
| Jun 30, 2021 | -252,000.00 |
| Mar 31, 2021 | 86,000.00 |